[1] [1] SOMMERLAD A, LIU K Y. Air pollution and dementia［J］. British Medical Journal, 2023, 381: 655.

[2] [2] KNOPMAN D S, AMIEVA H, PETERSEN R C, et al. Alzheimer disease［J］. Nature Reviews Disease Primers, 2021, 7(1): 33.

[3] [3] MOORE K B E, HUNG T J, FORTIN J S. Hyperphosphorylated tau (p-Tau) and drug discovery in the context of Alzheimer’s disease and related tauopathies［J］. Drug Discovery Today, 2023, 28(3): 103487.

[4] [4] ATHAR T, AL BALUSHI K, KHAN S A. Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease ［J］. Molecular Biology Reports, 2021, 48(7): 5629-5645.

[5] [5] MCGUFF P E, DETERLING R A, GOTTLIEB L S. Tumoricidal effect of laser energy on experimental and human malignant tumors［J］. New England Journal of Medicine, 1965, 273(9): 490-492.

[6] [6] MESTER E, SZENDE B, GARTNER P. The effect of laser beams on the growth of hair in mice［J］. Radiobiologia, Radiotherapia, 1968, 9(5): 621-626.

[7] [7] SALEHPOUR F, MAHMOUDI J, KAMARI F, et al. Brain photobiomodulation therapy: a narrative review［J］. Molecular Neurobiology, 2018, 55(8): 6601-6636.

[8] [8] BAROLET A C, VILLARREAL A M, JFRI A, et al. Low-intensity visible and near-infrared light-induced cell signaling pathways in the skin: a comprehensive review［J］. Photobiomodulation, Photomedicine, and Laser Surgery, 2023, 41(4): 147-166.

[9] [9] HAMBLIN M R. Shining light on the head: photobiomodulation for brain disorders［J］. BBA Clinical, 2016, 6: 113-124.

[10] [10] TAYEBI H, AZADNAJAFABAD S, MAROUFI S F, et al. Applications of brain-computer interfaces in neurodegenerative diseases ［J］. Neurosurgical Review, 2023, 46(1): 131.

[11] [11] HOPMANN C, ROBIG M. Injection moulding of high precision optics for light-emitting diodes made of liquid silicone rubber［J］.Journal of Elastomers & Plastics, 2017, 49(1): 62-76.

[12] [12] WU S, XIONG P, LIU Q, et al. Self-activated tungstate phosphor for near-infrared light-emitting diodes［J］. Advanced Optical Materials, 2022, 10(23): 2201718.

[13] [13] TAO L, LIU Q, ZHANG F, et al. Microglia modulation with 1 070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer’s disease mouse model［J］. Light: Science & Applications, 2021, 10(1): 179.

[14] [14] SALEHPOUR F, GHOLIPOUR-KHALILI S, FARAJDOKHT F, et al. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review［J］. Reviews in the Neurosciences, 2020, 31(3): 269-286.

[15] [15] SEDIVA E, DOSTALOVA T, URBANOVA P, et al. Photobiomodulation therapy after mesiodens surgery: evaluation of immunological markers and three-dimensional X-ray analysis―placebocontrolled study［J］. Photobiomodulation, Photomedicine, and Laser Surgery, 2022, 40(7): 472-479.

[16] [16] QI Yun, LI Dake. Exploring the workings of the human brain, U.S. plans to map brain activity［J］. The Tide of Science & Technology, 2013 (4): 50-53.

[17] [17] POO M M, DU J L, IP NANCY Y, et al. China brain project: basic neuroscience, brain diseases, and brain-inspired computing［J］. Neuron, 2016, 92(3): 591-596.

[18] [18] ZHONG Wen, SHEN Xiaozhu, XU Yiwen, et al. Research progress and prospect of non-drug therapy for Alzheimer’s disease［J］.Journal of Apoplexy and Nervous Diseases, 2023, 40(2): 177-181.

[19] [19] KATER M S J, HUFFELS C F M, OSHIMA T, et al. Prevention of microgliosis halts early memory loss in a mouse model of Alzheimer’s disease［J］. Brain, Behavior, and Immunity, 2023, 107: 225-241.

[20] [20] KARRAN E, DE STROOPER B. The amyloid hypothesis in Alzheimer’s disease: new insights from new therapeutics［J］. Nature Reviews Drug Discovery, 2022, 21(4): 306-318.

[21] [21] GHAZIMORADI M M, POUR G M, GHOUSHI E, et al. A review on garlic as a supplement for Alzheimer’s disease: a mechanistic insight into its direct and indirect effects［J］. Current Pharmaceutical Design, 2023, 29(7): 519-526.

[22] [22] ABBOTT A. Are infections seeding some cases of Alzheimer’s disease?［J］. Nature, 2020, 587(7832): 22-25.

[23] [23] BALLATORE C, LEE V M Y, TROJANOWSKI J Q. Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders ［J］. Nature Reviews Neuroscience, 2007, 8(9): 663-672.

[24] [24] NIZYNSKI B, DZWOLAK W, NIEZNANSKI K. Amyloidogenesis of Tau protein［J］. Protein Science, 2017, 26(11): 2126-2150.

[25] [25] YIN Ruijia, GUAN Li, BAI Chunhua, et al. Progress in the pathogenesis and drug development of Alzheimer’s disease［J］. Biological Chemical Engineering, 2021, 7(1): 170-172.

[26] [26] ZHU C C, FU S Y, CHEN Y X, et al. Advances in drug therapy for Alzheimer’s disease［J］. Current Medical Science, 2020, 40(6):999-1008.

[27] [27] PANZA F, SOLFRIZZI V, SERIPA D, et al. Tau-based therapeutics for Alzheimer’s disease: active and passive immunotherapy ［J］. Immunotherapy, 2016, 8(9): 1119-1134.

[28] [28] KONTSEKOVA E, ZILKA N, KOVACECH B, et al. First-inman tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model［J］. Alzheimer’s Research & Therapy, 2014, 6(4): 44.

[29] [29] HUANG Qiang, SANG Shaoming, PAN Xiaoli, et al. Advance on the clinical research of Alzheimer’s disease treatment［J］. Chinese Journal of Clinical Medicine, 2023, 30(2): 199-208.

[30] [30] XU Jiyi, ZHOU Zhi, QIN Bin. Research advances in anti-Aβ targeted therapy for Alzheimer’s disease: an update［J］. Chinese Journal of Geriatrics, 2019, 38(12): 1441-1444.

[31] [31] FILHO C E C, LOSS L B, MARCOLONGO-PEREIRA C, et al. Advances in Alzheimer’s disease’s pharmacological treatment［J］. Front Pharmacol, 2023, 14: 1101452.

[32] [32] BUDD HAEBERLEIN S, AISEN P S, BARKHOF F, et al. Two randomized phase 3 studies of aducanumab in early Alzheimer’s disease［J］. The Journal of Prevention of Alzheimer’s Disease, 2022, 9(2): 197-210.

[33] [33] VAN DYCK C H, SWANSON C J, AISEN P, et al. Lecanemab in early Alzheimer’s disease［J］. New England Journal of Medicine, 2022, 388(1): 9-21.

[34] [34] MELCHIORRI D, MERLO S, MICALLEF B, et al. Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?［J］. Front Pharmacol, 2023, 14: 1196413.

[35] [35] ZHANG Yinglin, YAO Junyan. Research progress on the role of neuroinflammation in Alzheimer’s disease disease［J］. International Journal of Anesthesiology and Resuscitation, 2022, 43(1): 90-94.

[36] [36] LIU P, WANG Y Y, SUN Y, et al. Neuroinflammation as a potential therapeutic target in Alzheimer’s disease［J］. Clinical Interventions in Aging, 2022, 17: 665-674.

[37] [37] MOUTINHO S. The long road to a cure for Alzheimer’s disease is paved with failures［J］. Nature Medicine, 2022, 28(11): 2228-2231.

[38] [38] SUO Zongwu, WEI Kaixin, XU Yi, et al. Research progress on natural products improving Alzheimer’s disease by regulating neuroinflammation ［J］. Chinese Traditional and Herbal Drugs, 2023, 54(7): 2284-2300.

[39] [39] TIAN C, STEWART T, HONG Z, et al. Blood extracellular vesicles carrying synaptic function- and brain-related proteins as potential biomarkers for Alzheimer’s disease［J］. Alzheimer’s & Dementia, 2023, 19(3): 909-923.

[40] [40] CHERNYAEVA L, RATTI G, TEIRILA L, et al. Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation［J］. EMBO Reports, 2023, 24(7): e56467.

[41] [41] PARDO-MORENO T, GONZALEZ-ACEDO A, RIVAS-DOMíNGUEZ A, et al. Therapeutic approach to Alzheimer’s disease: current treatments and new perspectives［J］. Pharmaceutics, 2022, 14(6): 1117.

[42] [42] TEZEL G, TIMUR S S, BOZKURT I, et al. A snapshot on the current status of Alzheimer’s disease, treatment perspectives, in-vitro and in-vivo research studies and future opportunities［J］. Chemi-cal and Pharmaceutical Bulletin, 2019, 67(10): 1030-1041.

[43] [43] MICHAEL R H. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation［J］. AIMS Biophysics, 2017, 4(3): 337-361.

[44] [44] SYED S B, AHMET I, CHAKIR K, et al. Photobiomodulation therapy mitigates cardiovascular aging and improves survival［J］. Lasers in Surgery and Medicine, 2023, 55(3): 278-293.

[45] [45] DE SOUSA M V P, KAWAKUBO M, FERRARESI C, et al. Pain management using photobiomodulation: mechanisms, location, and repeatability quantified by pain threshold and neural biomarkers in mice［J］. Journal of Biophotonics, 2018, 11(7): e201700370.

[46] [46] KESHARWANI D, THAPA MAGAR S, RAWASHDEH M, et al. 1 448 photobiomodulation (PBM) therapy in resistant chronic ulcers caused by kaposi’s sarcoma: an effective adjunct for wound healing［J］. British Journal of Surgery, 2021, 108(Supplement_6): 378.

[47] [47] SALEHPOUR F, KHALILI S G, FARAJDOKHT F, et al. Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review［J］. Reviews in the Neurosciences, 2020, 31(3): 269-286.

[48] [48] SU C T, WU J H. Management of combined therapy (Ceritinib, A. cinnamomea, G. lucidum, and photobiomodulation) in advanced non-small-cell lung cancer: a case report［J］. Life, 2022, 12(6): 862.

[49] [49] PURUSHOTHUMAN S, JOHNSTONE D M, NANDASENA C, et al. Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex: evidence from two transgenic mouse models［J］. Alzheimer’s Research & Therapy, 2014, 6(1): 2.

[50] [50] EKICI O, DüNDAR ü, BüYüKBOSNA M. Effectiveness of high-intensity laser therapy in patients with myogenic temporomandibular joint disorder: a double-blind, placebo-controlled study［J］. Journal of Stomatology Oral and Maxillofacial Surgery, 2022, 123(3): e90-e96.

[51] [51] DELLA SANTA G M L, FERREIRA M C, MACHADO T P G, et al. Effects of photobiomodulation therapy (LED 630 nm) on muscle and nerve histomorphometry after axonotmesis［J］. Photochemistry and Photobiology, 2021, 97(5): 1116-1122.

[52] [52] SHAMLOO S, DEFENSOR E, CIARI P, et al. The anti-inflammatory effects of photobiomodulation are mediated by cytokines: evidence from a mouse model of inflammation［J］. Frontiers in Neurorobotics, 2023, 17: 1150156.

[54] [54] YANG M, YANG Z, WANG P, et al. Current application and future directions of photobiomodulation in central nervous diseases ［J］. Neural Regeneration Research, 2021, 16(6): 1177-1185.

[55] [55] WEI Xunbin, ZHOU Feifan, TAO Lechan, et al. Phototherapy of neurodegenerative diseases: mechanism, application, and prospect ［J］. Strategic Study of CAE, 2020, 22(3): 108-116.

[56] [56] ABIJO A, LEE C Y, HUANG C Y, et al. The beneficial role of photobiomodulation in neurodegenerative diseases［J］. Biomedicines, 2023, 11(7): 1828.

[57] [57] LI Qian, WANG Miao, ZHOU Feifan. Potential application of photobiomodulation in the treatment of Alzheimer’s disease［J］. Progress in Biochemistry and Biophysics, 2023, 50(8): 1826-1840.

[58] [58] IACCARINO H F, SINGER A C, MARTORELL A J, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia［J］. Nature, 2016, 540(7632): 230-235.

[59] [59] HAN M, WANG Q, WANG X, et al. Near infra-red light treatment of Alzheimer’s disease［J］. Journal of Innovative Optical Health Sciences, 2017, 11(1): 1750012.

[60] [60] HAMBLIN M R. Mechanisms and mitochondrial redox signaling in photobiomodulation［J］. Photochemistry and Photobiology, 2018, 94(2): 199-212.

[61] [61] ENENGL J, HAMBLIN M R, DUNGEL P. Photobiomodulation for Alzheimer’s disease: translating basic research to clinical application［J］. Journal of Alzheimer’s Disease, 2020, 75(4): 1073-1082.

[62] [62] BHATTACHARYA M, DUTTA A. Computational modeling of the photon transport, tissue heating, and cytochrome c oxidase absorption during transcranial near-infrared stimulation［J］. Brain Sciences, 2019, 9(8): 179.

[63] [63] SU M, NIZAMUTDINOV D, LIU H, et al. Recent mechanisms of neurodegeneration and photobiomodulation in the context of Alzheimer’s disease［J］. International Journal of Molecular Sciences, 2023, 24(11): 9272.

[64] [64] HAMBLIN M R. Photobiomodulation for Alzheimer’s disease: has the light dawned?［J］. Photonics, 2019, 6(3): 77.

[65] [65] FARFARA D, TUBY H, TRUDLER D, et al. Low-level laser therapy ameliorates disease progression in a mouse model of Alzheimer’s disease［J］. Journal of Molecular Neuroscience, 2015, 55(2): 430-436.

[66] [66] DE TABOADA L, YU J, EL-AMOURI S, et al. Transcranial laser therapy attenuates amyloid-β peptide neuropathology in amyloid-β protein precursor transgenic mice［J］. Journal of Alzheimer’s Disease, 2011, 23: 521-535.

[67] [67] BLIVET G, MEUNIER J, ROMAN F J, et al. Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: novel hypothesis for therapeutic approach of Alzheimer’s disease suggested［J］. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 2018, 4(1): 54-63.

[68] [68] CARDOSO F D S, LOPES MARTINS R á B, GOMES DA SILVA S. Therapeutic potential of photobiomodulation in Alzheimer’s disease: a systematic review［J］. Journal of Lasers in Medical Sciences, 2020, 11(Suppl 1): S16-S22.

[69] [69] ZHANG R, ZHOU T, LIU L, et al. Dose-effect relationships for PBM in the treatment of Alzheimer’s disease［J］. Journal of Physics D: Applied Physics, 2021, 54(35): 33-45.

[70] [70] ZHANG Z, SHEN Q, WU X, et al. Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer’s disease models［J］. Aging Cell, 2020, 19(1): e13054.

[71] [71] PURUSHOTHUMAN S, JOHNSTONE D M, NANDASENA C, et al. Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex: evidence from two transgenic mouse models［J］. Alzheimer’s Research & Therapy 2014, 6(1): 2.

[72] [72] ENENGL J, HAMBLIN M R, DUNGEL P. Photobiomodulation for Alzheimer’s disease: translating basic research to clinical application ［J］. Journal of Alzheimer’s Disease, 2020, 75: 1073-1082.

[73] [73] BARRETT D W, GONZALEZ-LIMA F. Transcranial infrared laser stimulation produces beneficial cognitive and emotional effects in humans［J］. Neuroscience, 2013, 230: 13-23.

[74] [74] CHAN A S, LEE T L, YEUNG M K, et al. Photobiomodulation improves the frontal cognitive function of older adults［J］. International Journal of Geriatric Psychiatry, 2019, 34(2): 369-377.

[75] [75] SALTMARCHE A, NAESER M A, HO K F, et al. 383. Transcranial plus intranasal photobiomodulation in mild to moderatelysevere dementia［J］. Biological Psychiatry, 2017, 81(10): S156-S157.

[76] [76] SALTMARCHE A E, NAESER M A, HO K F, et al. Significant improvement in cognition in mild to moderately severe dementia cases treated with transcranial plus intranasal photobiomodulation: case series report［J］. Photomedicine and Laser Surgery, 2017, 35(8): 432-441.

[77] [77] SALEHPOUR F, KHADEMI M, HAMBLIN M R. Photobiomodulation therapy for dementia: a systematic review of pre-clinical and clinical studies［J］. Journal of Alzheimer’s Disease, 2021, 83(4): 1431-1452.

[78] [78] MAKSIMOVICH I. Endovascular application of low-energy laser in the treatment of dyscirculatory angiopathy of Alzheimer’s type ［J］. Journal of Behavioral and Brain Science, 2012, 2(1): 67-81.

[79] [79] BERMAN M H, HALPER J P, NICHOLS T W, et al. Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memory and cognition［J］. Journal of Neurology and Neuroscience, 2017, 8(1): 176.

[80] [80] ARAKELYAN H S. Treatment of Alzheimer’s disease with a combination of laser, magnetic field and chromo light (colour) therapies: a double-blind controlled trial based on a review and overview of the etiological pathophysiology of Alzheimer’s disease［J］. Laser Therapy, 2005, 14: 19-28.

[81] [81] MAKSIMOVICH I V. Dementia and cognitive impairment reduction after laser transcatheter treatment of Alzheimer’s disease［J］. World Journal of Neuroscience, 2015, 5: 189-203.

[82] [82] NIZAMUTDINOV D, QI X, BERMAN M H, et al. Photobiomodulation with near infrared light helmet in a pilot, placebo controlled clinical trial in dementia patients testing memorg and congition［J］. Aging and Disease, 2021, 12(4): 954-963.

[83] [83] CHAN A S, LEE T L, HAMBLIN M R, et al. Photobiomodulation enhances memory processing in older adults with mild cognitive impairment: a functional near-infrared spectroscopy study［J］. Journal of Alzheimer’s Disease, 2021, 83: 1471-1480.

[84] [84] ZUPIN L, CELSI F, OTTAVIANI G, et al. Photobiomodulation therapy at different wavelength impacts on retinoid acid-dependent SH-SY5Y differentiation［J］. Lasers in Medical Science, 2020, 35(1): 221-226.

[85] [85] SILVEIRA P C L, FERREIRA G K, ZACCARON R P, et al. Effects of photobiomodulation on mitochondria of brain, muscle, and C6 astroglioma cells［J］. Medical Engineering & Physics, 2019, 71: 108-113.

[86] [86] DUGGETT N A, CHAZOT P L. Low-intensity light therapy (1 068 nm) protects cad neuroblastoma cells from β-amyloidmediated cell death［J］. Biology and Medicine, 2014, 6(3): 1-6.

[87] [87] FURCILA D, DEFELIPE J, ALONSO-NANCLARES L. A study of amyloid-β and phosphotau in plaques and neurons in the hippocampus of Alzheimer’s disease patients［J］. Journal of Alzheimer’s Disease, 2018, 64: 417-435.

[88] [88] SOMERA B, FRICK M, FADEL J R. Age-related changes in basal forebrain afferent activation in response to food paired stimuli［J］. Neuroscience Letters, 2023, 802: 137155.

[89] [89] BAZZARI F H, BAZZARI A H. Bace1 inhibitors for Alzheimer’s disease: the past, present and any future?［J］. Molecules, 2022, 27(24): 8823.